A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

Summary

This is a multicenter, randomized, double-blind, placebo-controlled Phase 1b study in adult participants with tinea pedis caused by dermatophytes. The study will evaluate the safety, local tolerability, and pharmacokinetic profile of two concentrations of ZYG24004 (1% and 3%) after topical administration once or twice (once weekly for two consecutive weeks), and will explore preliminary efficacy.

Timeline

Start

2026-07-03

Primary completion

2027-06-10

Completion

2027-06-10

Drugs

Indications